Christina Arevalo, MS

Alkermes, Inc, Waltham, Massachusetts

  • 3Articles
  • 21.3KReads
  • 2023–2026Active
  • 12Collaborators
  • 27Citations

About

Christina Arevalo, MS, is affiliated with Alkermes, Inc, Waltham, Massachusetts. Her publications focus on the treatment of schizophrenia, schizoaffective disorders, and bipolar disorder, with particular attention to the effects of olanzapine combined with samidorphan. She has contributed to studies examining the efficacy, long-term safety, and tolerability of this treatment, including analyses in early illness stages and assessments of weight-related outcomes. Her work has been published in Psychiatrist.com between 2023 and 2026.

Publications

JCP
Efficacy of Olanzapine/Samidorphan on Negative Symptoms
Original Research

Efficacy of Olanzapine/Samidorphan on Negative Symptoms

March 9, 2026

Olanzapine/samidorphan was associated with significant and durable improvement in negative symptoms of schizophrenia, overall and among patients with prominent and predominant negative symptoms.
, , , et al
JCP
Long-Term Safety and Treatment Effect of Olanzapine/Samidorphan
Original Research

Long-Term Safety and Treatment Effect of Olanzapine/Samidorphan

December 4, 2024

During up to 4 years of treatment, the combination of olanzapine/samidorphan was safe and well-tolerated, and patients’ symptoms remained stable.
, , , et al
JCP
Olanzapine/Samidorphan Mitigates Weight Gain in Early Illness
Original Research

Olanzapine/Samidorphan Mitigates Weight Gain in Early Illness

March 22, 2023

In patients with early-phase schizophrenia or bipolar disorder, combination olanzapine and samidorphan resulted in less weight gain at week 12 than olanzapine alone. Antipsychotic efficacy was similar between the...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe